Publication Name	World Journal of Experimental Medicine
Manuscript ID	89320
Country	Greece

Received	2023-10-27 17:32
Peer-Review Started	2023-10-27 17:34
First Decision by Editorial Office Director	2023-11-30 07:49
Return for Revision	2023-11-30 07:49
Revised	2023-12-11 18:15
Publication Fee Transferred
Second Decision by Editor	2023-12-21 03:18
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2023-12-28 07:32
Articles in Press	2023-12-28 07:32
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-14 08:18
Publish the Manuscript Online	2024-03-19 14:54

ISSN	2220-315x (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Opinion Review
Article Title	Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes
Manuscript Source	Invited Manuscript
All Author List	Charalampos Milionis, Ioannis Ilias, Anastasia Lekkou, Evangelia Venaki and Eftychia Koukkou
ORCID	Author(s) ORCID Number Charalampos Milionis http://orcid.org/0000-0003-2442-3772 Ioannis Ilias http://orcid.org/0000-0001-5718-7441 Evangelia Venaki http://orcid.org/0000-0001-8942-2039 Eftychia Koukkou http://orcid.org/0000-0002-1433-3151
Funding Agency and Grant Number
Corresponding Author	Charalampos Milionis, MD, PhD, Consultant Physician-Scientist, Department of Endocrinology, Diabetes, and Metabolism, ’Elena Venizelou’ General Hospital, Elena Venizelou Square 2, Athens 11521, Greece. pesscharis@hotmail.com
Key Words	C-peptide; Gestational diabetes; Secondary prevention; Pregnancy; Clinical laboratory techniques
Core Tip	Understanding the diagnostic role of C-peptide measurements in predicting hyperglycemia during pregnancy can facilitate timely interventions in clinical practice, potentially preventing gestational diabetes in a subset of predisposed women. Further research is necessary to confirm the utility of C-peptide testing in pregnancy and define the appropriate diagnostic thresholds.
Publish Date	2024-03-19 14:54
Citation	Milionis C, Ilias I, Lekkou A, Venaki E, Koukkou E. Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes. World J Exp Med 2024; 14(1): 89320
URL	https://www.wjgnet.com/2220-315x/full/v14/i1/89320.htm
DOI	https://dx.doi.org/10.5493/wjem.v14.i1.89320

Full Article (PDF)	WJEM-14-89320-with-cover.pdf
Manuscript File	89320_Auto_Edited-YJP.docx
Answering Reviewers	89320-Answering reviewers.pdf
Audio Core Tip	89320-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89320-Conflict-of-interest statement.pdf
Copyright License Agreement	89320-Copyright license agreement.pdf
Peer-review Report	89320-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	89320-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	89320-Bing-Li L-2.png
Scientific Editor Work List	89320-Scientific editor work list.pdf
CrossCheck Report	89320-CrossCheck report.pdf
CrossCheck Report	89320-CrossCheck.png